Tau PET in Imaging and Cognition: Healthy Adults From 55-90
Yaakov Stern · with National Institute on Aging (NIA) · NCT03372317
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 55–90 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 105
- US sites recruiting
- 1
- Study start
- June 1, 2018
- Record last updated
- February 11, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The investigators aim to use the new PET radioligand, 18F-MK-6240, to detect tau pathology in cognitive healthy and mild cognitive impairment (MCI) elders. The investigators will then examine the interactions between differential tau burden and performance on cognitive tasks, functional magnetic resonance imaging (fMRI) neural activation patterns, and other cognitive and behavioral measures. By investigating these relationships, the investigators hope to understand the cognitive and behavioral outcomes of tau deposition found in specific brain regions in cognitively normal/mildly cognitively impaired adults. Furthermore, the study aims to examine how the presence of tau may contribute to the risk of subsequent cognitive decline, neurodegeneration, and dementia.
Being studied: 18F-MK-6240
Conditions: Mild Cognitive Impairment; Aging
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Aged 55-90
- Previously received an amyloid PET scan
- Residing near Columbia University Medical Center
- Must be willing and able to participate
Exclusion Criteria
- Have a contraindication to PET (e.g, metallic implants, pacemaker, claustrophobia, or cannot lie flat for one hour)
- Pregnancy
- Lactating Women
- Current, past, or anticipated exposure to radiation
- Significant active physical illness
Recruiting US locations
Columbia University Medical Center
New York, NY 10032
Site contact: Ashley Mensing, BS · 212-305-6314 · ao2454@cumc.columbia.edu
Study contacts (from the official record)
- Reshma Babukutty · 212-305-6314 · rb2996@cumc.columbia.edu
Similar studies in New York
All neurology studies in New York →- RecruitingHealthy volunteersPhase 1
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Suninflam Inc
- Location
- Amherst, NY + 9 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersEarly Phase 1
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
Northwell Health
- Location
- Manhasset, NY
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1
Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches
State University of New York - Upstate Medical University
- Location
- Syracuse, NY
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteers
MyVitalC: Sleep and Everyday Headache Management
Efforia, Inc
- Location
- New York, NY
- Eligibility basics
- Any age listed